Live Nasdaq Composite: OpenAI IPO Delay Fears Send Markets Out on Sour Note

Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

652 Articles

Lee Jackson | Oct 23, 2015 at 8:35 AM EDT

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and…

Chris Lange | Oct 22, 2015 at 10:45 AM EDT

Eli Lilly Rises on Bottom Line Beat

Eli Lilly reported mixed third-quarter financial results on Thursday before the markets opened.

Chris Lange | Oct 21, 2015 at 2:30 PM EDT

What to Expect From Eli Lilly Earnings

Eli Lilly is scheduled to report its third-quarter earnings before the markets open on Thursday.

Jon C. Ogg | Oct 17, 2015 at 9:15 AM EDT

6 Big Companies That Severely Stung Shareholders This Past Week

While there were many winners, last week brought a lot of truly bad news or bad reactions for some of…

Jon C. Ogg | Oct 12, 2015 at 9:55 AM EDT

Eli Lilly Stumbles on Discontinued Drug Trial

Eli Lilly is suffering after bad news about its evacetrapib for high-risk atherosclerotic cardiovascular disease.

Chris Lange | Oct 9, 2015 at 11:20 AM EDT

Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher

Credit Suisse sees solid upside in this company Eli Lilly as the result of a strong pipeline, with its Alzheimer's…

Jon C. Ogg | Oct 9, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

Friday's top analyst upgrades, downgrades and initiations include AT&T, BioCryst Pharmaceuticals, Eli Lilly, Facebook, Flextronics, Gap and Tesla Motors.

Lee Jackson | Oct 2, 2015 at 10:25 AM EDT

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

Wikimedia CommonsIf there was ever a time when investors are thrilled to see the calendar change it could be now.…

Lee Jackson | Oct 2, 2015 at 9:20 AM EDT

4 Top Merrill Lynch US Defensive Stock Ideas for Q4

After the worst quarter in the stock market in four years, a new research report from Merrill Lynch includes the…

Lee Jackson | Sep 30, 2015 at 8:35 AM EDT

Merrill Lynch Makes Changes to US 1 List Amid Market Turmoil

The market volatility has left all investors a touch shaken, but the chatter of a bear market and a collapse…

Lee Jackson | Sep 24, 2015 at 9:45 AM EDT

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

One positive from the hammering the pharmaceutical stocks have taken is the Merrill Lynch analysts say investors have been given…

Chris Lange | Sep 18, 2015 at 11:45 AM EDT

Why Merrill Lynch Sees More Upside in Eli Lilly

Merrill Lynch reiterated a Buy rating and price objective on Eli Lilly after positive data on its Jardiance.

Lee Jackson | Sep 18, 2015 at 9:25 AM EDT

History Says Market Could Retest Lows: 4 Safe Stocks to Buy

The gut-wrenching drop back in August, when the Dow opened down 1,000 points and the indexes went through the first…

Jon C. Ogg | Sep 18, 2015 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Eli Lilly, Gilead, Royal Gold, Sirius XM and Many More

Friday’s top analyst upgrades, downgrades and initiations include Aetna, Eli Lilly, Gilead Sciences, Royal Gold and Sirius XM.

Chris Lange | Aug 20, 2015 at 11:15 AM EDT

Eli Lilly Continues to Rise on Positive Jardiance Results

Eli Lilly shares got a solid boost in the market Thursday morning as the broad markets were selling off.

1 … 30 31 32 33 34 … 44

Eli Lilly : LLY

All Eli Lilly Articles

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

Eli Lilly Rises on Bottom Line Beat

What to Expect From Eli Lilly Earnings

6 Big Companies That Severely Stung Shareholders This Past Week

Eli Lilly Stumbles on Discontinued Drug Trial

Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

4 Top Merrill Lynch US Defensive Stock Ideas for Q4

Merrill Lynch Makes Changes to US 1 List Amid Market Turmoil

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

Why Merrill Lynch Sees More Upside in Eli Lilly

History Says Market Could Retest Lows: 4 Safe Stocks to Buy

Top Analyst Upgrades and Downgrades: Aetna, Eli Lilly, Gilead, Royal Gold, Sirius XM and Many More

Eli Lilly Continues to Rise on Positive Jardiance Results

Live Nasdaq Composite: OpenAI IPO Delay Fears Send Markets Out on Sour Note

25% Yield!? Why Robinhood Traders Are Piling Into This FANG Income ETF Like There’s No Tomorrow

A Couple Built a Treasury Ladder for Safe Income. The Yields Nudged Them Toward Medicare’s $218,000 IRMAA Cliff.

Nobody Wants To Retire In North Dakota. Maybe That’s Exactly Why You Should.

A Couple Built a Treasury Ladder for Safe Income. The Yields Nudged Them Toward Medicare's $218,000 IRMAA Cliff.

Nobody Wants To Retire In North Dakota. Maybe That's Exactly Why You Should.

25% Yield!? Why Robinhood Traders Are Piling Into This FANG Income ETF Like There’s No Tomorrow

A Couple Built a Treasury Ladder for Safe Income. The Yields Nudged Them Toward Medicare’s $218,000 IRMAA Cliff.

Eli Lilly : LLY

All Eli Lilly Articles

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

Eli Lilly Rises on Bottom Line Beat

What to Expect From Eli Lilly Earnings

6 Big Companies That Severely Stung Shareholders This Past Week

Eli Lilly Stumbles on Discontinued Drug Trial

Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

4 Top Merrill Lynch US Defensive Stock Ideas for Q4

Merrill Lynch Makes Changes to US 1 List Amid Market Turmoil

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

Why Merrill Lynch Sees More Upside in Eli Lilly

History Says Market Could Retest Lows: 4 Safe Stocks to Buy

Top Analyst Upgrades and Downgrades: Aetna, Eli Lilly, Gilead, Royal Gold, Sirius XM and Many More

Eli Lilly Continues to Rise on Positive Jardiance Results

Live Nasdaq Composite: OpenAI IPO Delay Fears Send Markets Out on Sour Note

25% Yield!? Why Robinhood Traders Are Piling Into This FANG Income ETF Like There’s No Tomorrow

A Couple Built a Treasury Ladder for Safe Income. The Yields Nudged Them Toward Medicare’s $218,000 IRMAA Cliff.

Nobody Wants To Retire In North Dakota. Maybe That’s Exactly Why You Should.

Featured Reads

A Couple Built a Treasury Ladder for Safe Income. The Yields Nudged Them Toward Medicare's $218,000 IRMAA Cliff.

Nobody Wants To Retire In North Dakota. Maybe That's Exactly Why You Should.